Centric Health | StockChase
11
Centric Health (CHH-T)

Last Price Recorded: $0.6900 on 2017-11-16

ON STOCKCHASE SINCE Jun 2012

other services

Centric Health



ABOUT CHARTS : These are thumbnail sketches of the stock prices, from the time of the opinions. The charts are not detailed, and are meant only to give an oveview (note the number of datapoints). The charts show one month of information or up to six months if you are a subscriber. Recent opinions will obviously have fewer datapoints then older opinions.


You are not seeing charts because you haven't logged in or haven't opted in

Date Signal Company Opinion Expert
2017-11-16
BUY

CHH-T

$0.690

Centric Health


He likes the company.  One division is an industrial pharmacy.  The other is private surgery.  There is increasing demand for both due to the aging demographic.  Analysts are gearing up for what they see as pretty good growth in the next couple of quarters.  Longer term it will do well also.  It is in the sweet spot.

other services

Fabrice Taylor

Publisher

2017-10-05
BUY

CHH-T

$0.760

Centric Health


A healthcare story with 2 parts. One is paid for private surgeries, which he thinks is going to get a big tailwind because governments are broke. The other side is industrial pharmacy which fills prescriptions for nursing homes, etc. Lower margins, but nice volumes.

other services

Fabrice Taylor

Publisher

2017-08-21
BUY

CHH-T

$0.750

Centric Health


It has not done anything since it was his top pick.  Nursing homes will send over scripts.  It is a play on demographics.  The demand for their services is going up and up.  It is high risk because it is small, but he thinks you will see good things.

other services

Fabrice Taylor

Publisher

CAUTIOUS
2017-06-22
BUY

CHH-T

$0.700

Centric Health


It is a big turnaround story over the last three years.  They managed to sell off a division for more than expected.  They are dispensing drugs through nursing homes.  They have automation to make sure all these multiple pill packs have all the right medications in them.  They get long term contracts to service these facilities.  The thought is that CHH-T will end up getting all the McKesson contracts after the acquisition of Rexall, CHH-T’s supplier.

other services

Bruce Campbell (2)

President & Portfolio Manager

BULLISH
2017-04-26
COMMENT

CHH-T

$0.810

Centric Health


There is a lot of room for them to grow on 2 fronts. They look after prescriptions for a long-term care facility and get paid a dispensing fee for that. From that perspective, they have lots of room to grow. They have a relationship with McKesson, which bought Rexall, and it was thought that they would get some of those contracts from McKesson which would increase their earnings and cash flow. The other side of the business is their surgical centres and are looking to increase the usage so they would be much more profitable.

other services

Bruce Campbell (2)

President & Portfolio Manager

2017-03-10
COMMENT

CHH-T

$0.720

Centric Health


Just reported earnings and the stock had a pretty dramatic selloff, especially based on the numbers. This has transitioned in that they’ve had higher revenue and earnings numbers, as well as higher margins. Feels the market got a little disappointed in the growth rate, but the company has actually said that it is going to be November before the transition from Riviera beds to Chartwell beds ends. The big catalyst to watch is the debt refinancing. They’ve stated they are 80% along with a major Canadian bank. That will be a huge savings for them. He added to his holdings on the last selloff.

other services

Bruce Campbell (2)

President & Portfolio Manager

OPTIMISTIC
2017-02-16
TOP PICK

CHH-T

$0.790

Centric Health


One division does private surgeries that are not covered by healthcare.  Every year they cut more and more services from provincial plans so there are more and more opportunities to use their services.  The other division is an industrial pharmacy that services businesses like seniors homes.  It is a turnaround story.  They used to have a lot of debt, but margins have improved.  He is impressed with management.  The stock has positive tailwinds and it is a turnaround story.  (Analysts’ target: $1.02).

other services

Fabrice Taylor

Publisher

SELECTIVE
2017-01-25
TOP PICK

CHH-T

$0.640

Centric Health


Feels there is a fair bit of catalyst on this. They have 2 parts to the business, a specialty pharmacy and some surgical centres. The specialty pharmacies are basically pharmacies for long-term care facilities. They have a contract with a long-term care facility, and get paid to basically package prescriptions up for them and get paid a dispensing fee. Have about 27,000 beds right now, and he can see another 20,000 beds coming in. (Analysts’ price target is $0.80.)

other services

Bruce Campbell (2)

President & Portfolio Manager

BULLISH
2015-03-11
COMMENT

CHH-T

$0.390

Centric Health


As far as the sector goes, they are in the right spot. Have just started to do more M&A and changing their business a little. He is watching this, but has other healthcare holdings that he likes better. Valuation is pretty good, and depending on what management does, there could be some potential for it to move higher.

other services

Bruce Campbell (2)

President & Portfolio Manager

2012-10-12
SELL

CHH-T

$0.650

Centric Health


Cut your losses. $.71 is the floor and it broke through there.

other services

Jeff Parent B. Eng. FCSI

Vice President and Portfolio Manager

BULL on ENERGY
2012-06-18
DON'T BUY

CHH-T

$0.850

Centric Health


CEO recently resigned and the last couple of quarters have been a disaster. There is a new management team. Grows by acquisition but doesn't think current management team can handle the strategy. Expect there will be more changes in the management team.
other services

Jason Donville

President & CEO

CAUTIOUSLY OPTIMISTIC
Showing 1 to 11 of 11 entries

No Comments.


You must be logged in to comment.